Aurobindo Pharma, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received approval from Health Canada -- a department of the Canadian government with responsibility for national public health -- for its abbreviated new drug submission Gabapentin capsules in 100mg, 300mg and 400mg strengths.
Hyderabad based Aurobindo Pharma Limited has received Health Canada approval for its Abbreviated New Drug Submission Gabapentin capsules 100mg, 300mg and 400mg.
